PRINCETON, NJ – Nov. 28, 2018 – Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced the launch of version 2.3 of its Trial Simulator software to help drug developers improve clinical trial design, resulting in greater likelihood of trial success.
LOUGHBOROUGH, England (Nov. 26, 2018) – Activate Science, an annual event series organised by Thermo Fisher Scientific and attended by laboratory personnel across Europe, reached delegates at 36 customer sites in 2018.
Emily Quinton, European Marketing Communications Manager, commented: “Activate Science has reached nearly 3,300 delegates in 10 European countries this year and provides a valuable opportunity to network and experience the latest innovations in laboratory products hands-on at customer sites.”
Air Liquide is pleased to announce their new site at Waterbeach in Cambridge.
In order to get closer to our customers and provide the service you require we are now closer than ever to your business.
- Expert support in Speciality and Industrial gas applications
- Fast delivery from stock
- All ranges of equipment and design assistance
Tel: 07970 234332
AMSBIO announces that induced pluripotent stem (iPS) cell expert - Dr Masato Nakagawa from the Nobel Prize winning Yamanaka Lab** at the Centre for iPS Cell Research and Application, Kyoto University, Japan will give 3 talks in the UK on the 10th and 11th December 2018.
State of the discovery nation survey closing soon – still time to get your views heard!
Medicines Discovery Catapult is preparing our annual report for next year, which is based on the experience of companies in the sector – like you. We want to ensure your views are reflected.
Acquisition increases BioIVT’s supply of leukopaks, plasma and sera, and enhances its ability to support the in vitro diagnostic market
Wickham Laboratories will be exhibiting at Pharmig’s 26th annual conference held on the 28th & 29th November at the Belfry Hotel, Nottingham.
This year’s event will bring together an array of industry experts and regulators to discuss the latest research and findings within the pharmaceutical microbiology industry.
The conference programme will include the following topics among others: